• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Zura Bio Limited - Class A Ordinary shares (NQ:ZURA)

    4.625 +0.085 (+1.87%)
    Streaming Delayed Price Updated: 9:40 AM EDT, Jun 26, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 20,492
    Open 4.500
    Bid (Size) 4.590 (500)
    Ask (Size) 4.670 (100)
    Prev. Close 4.540
    Today's Range 4.470 - 4.680
    52wk Range 1.000 - 7.440
    Shares Outstanding 62,064,270
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Zura Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
    From Zura Bio Limited
    Via Business Wire
    News headline image
    Zura Bio Expands Leadership Team with Appointment of Muzammil Mustufa as Chief Business Officer
    From Zura Bio Limited
    Via Business Wire

    Performance

    YTD
    -16.7%
    -16.7%
    1 Month
    +9.9%
    +9.9%
    3 Month
    -23.4%
    -23.4%
    6 Month
    -0.5%
    -0.5%
    1 Year
    +291.9%
    +291.9%

    More News

    Read More
    ZURA BIO LTD (NASDAQ:ZURA) Q1 2026: Cash Runway Extended Through 2028 as Phase 2 Trials Advance ↗
    Via Chartmill
    News headline image
    Zura Bio Reports First Quarter 2026 Financial Results and Recent Corporate Updates
    From Zura Bio Limited
    Via Business Wire
    News headline image
    Zura Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
    From Zura Bio Limited
    Via Business Wire
    News headline image
    Zura Bio Reports Full Year 2025 Financial Results and Recent Corporate Updates
    From Zura Bio Limited
    Via Business Wire
    News headline image
    Zura Bio to Present Phase 2 TibuSURE Study Design Poster Evaluating Dual IL-17A and BAFF Inhibition in Systemic Sclerosis at 9th Systemic Sclerosis World Congress
    From Zura Bio Limited
    Via Business Wire
    News headline image
    Zura Bio to Participate in Upcoming Investor Conferences
    From Zura Bio Limited
    Via Business Wire
    News headline image
    Zura Bio Announces Closing of its $144 Million Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
    From Zura Bio Limited
    Via Business Wire
    News headline image
    Apogee Therapeutics Stock Up 100% as Fund Lifts Stake to $28 Million ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    This Fund Bet $20 Million on RAPT Therapeutics as Stock Surges 500% This Past Year and Buyout Offer Emerges ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Disc Medicine Lands New $20 Million Investment as FDA Sets Up Potential Q4 Catalyst ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Zura Bio Announces Pricing of $125 Million Public Offering of Class A Ordinary Shares and Pre-Funded Warrants
    From Zura Bio Limited
    Via Business Wire
    News headline image
    Zura Bio Announces Proposed Public Offering of Class A Ordinary Shares and Pre-Funded Warrants
    From Zura Bio Limited
    Via Business Wire
    News headline image
    Zura Bio Welcomes Accomplished Drug Development Leaders Mark Eisner, M.D., M.P.H., and Ajay Nirula, M.D., Ph.D., to Board of Directors
    From Zura Bio Limited
    Via Business Wire
    News headline image
    Zura Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit
    From Zura Bio Limited
    Via Business Wire
    News headline image
    Zura Bio Appoints Immunology Industry Leader Sandeep Kulkarni, M.D. as Chief Executive Officer
    From Zura Bio Limited
    Via Business Wire
    News headline image
    Zura Bio Reports Business Updates and Outlook for 2026
    From Zura Bio Limited
    Via Business Wire
    News headline image
    Zura Bio Reports Third Quarter 2025 Financial Results and Recent Corporate Updates
    From Zura Bio Limited
    Via Business Wire
    News headline image
    Unusual volume stocks are being observed in Wednesday's session. ↗
    Via Chartmill
    News headline image
    Here are the top movers in Tuesday's session. ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
    Via Benzinga
    News headline image
    These stocks are moving in today's session ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Monday's Intraday Session ↗
    Via Benzinga
    News headline image
    Top stock movements in today's session. ↗
    Via Chartmill

    Frequently Asked Questions

    Is Zura Bio Limited - Class A Ordinary shares publicly traded?
    Yes, Zura Bio Limited - Class A Ordinary shares is publicly traded.
    What exchange does Zura Bio Limited - Class A Ordinary shares trade on?
    Zura Bio Limited - Class A Ordinary shares trades on the Nasdaq Stock Market
    What is the ticker symbol for Zura Bio Limited - Class A Ordinary shares?
    The ticker symbol for Zura Bio Limited - Class A Ordinary shares is ZURA on the Nasdaq Stock Market
    What is the current price of Zura Bio Limited - Class A Ordinary shares?
    The current price of Zura Bio Limited - Class A Ordinary shares is 4.625
    When was Zura Bio Limited - Class A Ordinary shares last traded?
    The last trade of Zura Bio Limited - Class A Ordinary shares was at 06/26/26 09:40 AM ET
    What is the market capitalization of Zura Bio Limited - Class A Ordinary shares?
    The market capitalization of Zura Bio Limited - Class A Ordinary shares is 287.05M
    How many shares of Zura Bio Limited - Class A Ordinary shares are outstanding?
    Zura Bio Limited - Class A Ordinary shares has 287M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.